These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 24792351)

  • 21. Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors.
    Sharma H; Patil S; Sanchez TW; Neamati N; Schinazi RF; Buolamwini JK
    Bioorg Med Chem; 2011 Mar; 19(6):2030-45. PubMed ID: 21371895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
    Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
    Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
    Tripathy S; Azam MA; Jupudi S; Sahu SK
    J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel HIV-1 integrase inhibitors using shape-based screening, QSAR, and docking approach.
    Gupta P; Garg P; Roy N
    Chem Biol Drug Des; 2012 May; 79(5):835-49. PubMed ID: 22233531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T; Zhu L; Chen L; Xu X
    J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.
    Walker MA; Johnson T; Ma Z; Banville J; Remillard R; Kim O; Zhang Y; Staab A; Wong H; Torri A; Samanta H; Lin Z; Deminie C; Terry B; Krystal M; Meanwell N
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2920-4. PubMed ID: 16546383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacophore filtering and 3D-QSAR in the discovery of new JAK2 inhibitors.
    Dhanachandra Singh Kh; Karthikeyan M; Kirubakaran P; Nagamani S
    J Mol Graph Model; 2011 Sep; 30():186-97. PubMed ID: 21831680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational design and synthesis of novel dimeric diketoacid-containing inhibitors of HIV-1 integrase: implication for binding to two metal ions on the active site of integrase.
    Long YQ; Jiang XH; Dayam R; Sanchez T; Shoemaker R; Sei S; Neamati N
    J Med Chem; 2004 May; 47(10):2561-73. PubMed ID: 15115398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors.
    Deng J; Lee KW; Sanchez T; Cui M; Neamati N; Briggs JM
    J Med Chem; 2005 Mar; 48(5):1496-505. PubMed ID: 15743192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of TZD Scaffold as Potential ARIs: Pharmacophore Modeling, Atom-based 3D QSAR and Docking Studies.
    Dahiya L; Mahapatra MK; Kaur R; Kumar V; Kumar M
    Comb Chem High Throughput Screen; 2017; 20(4):310-320. PubMed ID: 28302016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Docking-based CoMFA and CoMSIA study of azaindole carboxylic acid derivatives as promising HIV-1 integrase inhibitors.
    Yu S; Wang P; Li Y; Liu Y; Zhao G
    SAR QSAR Environ Res; 2013 Oct; 24(10):819-39. PubMed ID: 23988186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study on the interactions between diketo-acid inhibitors and prototype foamy virus integrase-DNA complex via molecular docking and comparative molecular dynamics simulation methods.
    Hu JP; He HQ; Tang DY; Sun GF; Zhang YQ; Fan J; Chang S
    J Biomol Struct Dyn; 2013; 31(7):734-47. PubMed ID: 22913375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
    Neamati N; Hong H; Owen JM; Sunder S; Winslow HE; Christensen JL; Zhao H; Burke TR; Milne GW; Pommier Y
    J Med Chem; 1998 Aug; 41(17):3202-9. PubMed ID: 9703465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacophore modelling and electronic feature analysis of hydroxamic acid derivatives, the HIV integrase inhibitors.
    Sangeetha B; Muthukumaran R; Amutha R
    SAR QSAR Environ Res; 2013; 24(9):753-71. PubMed ID: 23710969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
    Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Four-dimensional structure-activity relationship model to predict HIV-1 integrase strand transfer inhibition using LQTA-QSAR methodology.
    de Melo EB; Ferreira MM
    J Chem Inf Model; 2012 Jul; 52(7):1722-32. PubMed ID: 22657398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore.
    Kehlenbeck S; Betz U; Birkmann A; Fast B; Göller AH; Henninger K; Lowinger T; Marrero D; Paessens A; Paulsen D; Pevzner V; Schohe-Loop R; Tsujishita H; Welker R; Kreuter J; Rübsamen-Waigmann H; Dittmer F
    J Virol; 2006 Jul; 80(14):6883-94. PubMed ID: 16809294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacophore development and docking studies of the hiv-1 integrase inhibitors derived from N-methylpyrimidones, Dihydroxypyrimidines, and bicyclic pyrimidinones.
    Telvekar VN; Patel KN
    Chem Biol Drug Des; 2011 Jul; 78(1):150-60. PubMed ID: 21518263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacophore, 3D-QSAR, and Bayesian model analysis for ligands binding at the benzodiazepine site of GABAA receptors: the key roles of amino group and hydrophobic sites.
    Yang Y; Zhang W; Cheng J; Tang Y; Peng Y; Li Z
    Chem Biol Drug Des; 2013 May; 81(5):583-90. PubMed ID: 23279907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Docking-based 3D-QSAR study of HIV-1 integrase inhibitors.
    Gupta P; Roy N; Garg P
    Eur J Med Chem; 2009 Nov; 44(11):4276-87. PubMed ID: 19647906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.